0

Journal Articles

in Vascular Surgery
 81-100 of 122 Articles
Editorial |  April 21, 2004
Off-Pump Bypass Surgery—Ready for the Big Dance?
Eric D. Peterson, MD, MPH; Daniel B. Mark, MD, MPH
JAMA. 2004;291(15):1897-1899. doi:10.1001/jama.291.15.1897.
Medical News and Perspectives |  April 21, 2004
Beat Goes On in "Off-Pump" Bypass Surgery
JAMA. 2004;291(15):1821-1822. doi:10.1001/jama.291.15.1821.
Original Contribution |  April 21, 2004 FREE
Off-Pump vs Conventional Coronary Artery Bypass Grafting: Early and 1-Year Graft Patency, Cost, and Quality-of-Life Outcomes:  A Randomized Trial
John D. Puskas, MD, MSc; Willis H. Williams, MD; Elizabeth M. Mahoney, ScD; et al.
JAMA. 2004;291(15):1841-1849. doi:10.1001/jama.291.15.1841.
Original Contribution |  February 25, 2004 FREE
Early Administration of Reteplase Plus Abciximab vs Abciximab Alone in Patients With Acute Myocardial Infarction Referred for Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Adnan Kastrati, MD; Julinda Mehilli, MD; Klaus Schlotterbeck, MD; et al.
JAMA. 2004;291(8):947-954. doi:10.1001/jama.291.8.947.
Medical News and Perspectives |  February 11, 2004
Drug-Eluting Stents Show Promise
JAMA. 2004;291(6):682-683. doi:10.1001/jama.291.6.682.
JAMA Patient Page |  February 11, 2004 FREE
Percutaneous Coronary Intervention
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2004;291(6):778. doi:10.1001/jama.291.6.778.
Editorial |  January 21, 2004
Ranolazine and Other Antianginal Therapies in the Era of the Drug-Eluting Stent
Peter Berger, MD
JAMA. 2004;291(3):365-367. doi:10.1001/jama.291.3.365.
Medical News and Perspectives |  October 22, 2003
Fake Worlds Offer Real Medicine
JAMA. 2003;290(16):2107-2112. doi:10.1001/jama.290.16.2107.
Original Contribution |  October 08, 2003 FREE
Mortality Benefit of Immediate Revascularization of Acute ST-Segment Elevation Myocardial Infarction in Patients With Contraindications to Thrombolytic Therapy:  A Propensity Analysis
Mary Grzybowski, PhD, MPH; Elizabeth A. Clements, PharmD; Lori Parsons, BS; et al.
JAMA. 2003;290(14):1891-1898. doi:10.1001/jama.290.14.1891.
Original Contribution |  September 24, 2003 FREE
Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary Syndromes:  A Randomized Controlled Trial
Franz-Josef Neumann, MD; Adnan Kastrati, MD; Gisela Pogatsa-Murray, MD; et al.
JAMA. 2003;290(12):1593-1599. doi:10.1001/jama.290.12.1593.
Special Communication |  May 21, 2003
Composite Outcomes in Randomized Trials:  Greater Precision But With Greater Uncertainty?
Nick Freemantle, PhD; Melanie Calvert, PhD; John Wood, MSc; et al.
JAMA. 2003;289(19):2554-2559. doi:10.1001/jama.289.19.2554.
Original Contribution |  March 05, 2003 FREE
Outcome of Elderly Patients With Chronic Symptomatic Coronary Artery Disease With an Invasive vs Optimized Medical Treatment Strategy:  One-Year Results of the Randomized TIME Trial
Matthias Pfisterer, MD, FESC, FAHA; Peter Buser, MD; Stefan Osswald, MD; et al.
JAMA. 2003;289(9):1117-1123. doi:10.1001/jama.289.9.1117.
Editorial |  February 19, 2003
Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?
Elliott M. Antman, MD
JAMA. 2003;289(7):903-905. doi:10.1001/jama.289.7.903.
Original Contribution |  February 19, 2003 FREE
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention:  REPLACE-2 Randomized Trial
A. Michael Lincoff, MD; John A. Bittl, MD; Robert A. Harrington, MD; et al.
JAMA. 2003;289(7):853-863. doi:10.1001/jama.289.7.853.
Original Contribution |  November 20, 2002 FREE
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Steven R. Steinhubl, MD; Peter B. Berger, MD; J. Tift Mann III, MD; et al.
JAMA. 2002;288(19):2411-2420. doi:10.1001/jama.288.19.2411.
Original Contribution |  August 28, 2002 FREE
Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention:  The Swiss Heart Study: A Randomized Controlled Trial
Guido Schnyder, MD; Marco Roffi, MD; Yvonne Flammer, MD; et al.
JAMA. 2002;288(8):973-979. doi:10.1001/jama.288.8.973.
Editorial |  June 26, 2002
Preventing Cardiac Events and Restenosis After Percutaneous Coronary Intervention
George Sopko, MD, MPH
JAMA. 2002;287(24):3259-3261. doi:10.1001/jama.287.24.3259.
Original Contribution |  June 26, 2002 FREE
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Patrick W. J. C. Serruys, MD, PhD; Pim de Feyter, MD; Carlos Macaya, MD; et al.
JAMA. 2002;287(24):3215-3222. doi:10.1001/jama.287.24.3215.
Editorial |  April 17, 2002
Primary Percutaneous Coronary Intervention for All?
Christopher P. Cannon, MD
JAMA. 2002;287(15):1987-1989. doi:10.1001/jama.287.15.1987.
Original Contribution |  April 17, 2002 FREE
Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery:  A Randomized Controlled Trial
Thomas Aversano, MD; Lynnet T. Aversano, RN, BSN; Eugene Passamani, MD; et al.
JAMA. 2002;287(15):1943-1951. doi:10.1001/jama.287.15.1943.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Facial Plastic Surgery
Original Article  |  March 21, 2013
Effects of Salivary Bypass Tubes on Fistula and Stricture Formation
Xerxes Punthakee, MD; Soroush Zaghi, MD; Vishad Nabili, MD; et al.
JAMA Dermatology
Observation  |  April 01, 2013
Cutaneous Epithelioid Sarcomalike (Pseudomyogenic) Hemangioendothelioma:  A Little-Known Low-Grade Cutaneous Vascular Neoplasm
Luis Requena, MD; Carlos Santonja, MD; Jose Luis Martinez-Amo, MD; et al.
JAMA Surgery
Original Article  |  December 17, 2012
Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease:  A Propensity Score–Adjusted, Population-Based Trend Analysis Involving 10 206 Patients
Mathias Worni, MD; Anthony W. Castleberry, MD; Bryan M. Clary, MD; et al.
JAMA Surgery
Invited Critique  |  December 17, 2012
Show Us the Money:  Comment on “Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease”
E. Christopher Ellison, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems